RESVERATROL: A MULTIFACETED NATURAL COMPOUND WITH THERAPEUTIC POTENTIAL
DOI:
https://doi.org/10.22159/ijpps.2026v18i1.57113Keywords:
Resveratrol, Polyphenol, Antioxidant, Cardioprotection, Neuroprotection, Anticancer, Anti-inflammatory, Anti-aging cream, bioavailabilityAbstract
Resveratrol, a plant-derived polyphenol abundant in grapes, berries, peanuts, and red wine, has been the subject of intense scientific exploration for more than three decades. First associated with the French Paradox, it is now widely studied for its ability to influence multiple biological pathways that underlie chronic disease and aging. Experimental evidence shows that resveratrol reduces oxidative stress, modulates inflammatory cascades, improves mitochondrial function, and regulates cell survival and metabolism. Through these actions, it exerts antioxidant, anti-inflammatory, cardioprotective, anticancer, neuroprotective, antidiabetic, hepatoprotective, antimicrobial, and anti-aging effects. While laboratory and animal studies provide compelling support, outcomes from human trials remain variable, reflecting challenges such as poor bioavailability, rapid metabolism, and differences in study design. Recent innovations including nanoparticle based carriers, synthetic analogs, and synergistic formulations are being developed to enhance its stability and clinical utility. Resveratrol is not a miracle cure, but rather a promising candidate for adjunct therapy, underscoring the potential of natural compounds to complement conventional medicine pending further clinical validation. Its journey underscores the need for rigorous, long-term, and well controlled clinical studies to establish effective doses, safety profiles, and therapeutic applications. By bridging traditional phytotherapy and modern translational science, resveratrol continues to inspire both researchers and clinicians in the search for holistic approaches to health and disease management.
Downloads
References
1. Wang DG, Liu WY, Chen GT. A simple method for the isolation and purification of resveratrol from Polygonum cuspidatum. J Pharm Anal. 2013 Aug;3(4):241–7.
2. Catalgol B, Batirel S, Taga Y, Ozer NK. Resveratrol: French Paradox Revisited. Front Pharmacol. 2012;3.
3. Orallo F. Comparative studies of the antioxidant effects of cis- and trans-resveratrol. Curr Med Chem. 2006;13(1):87–98.
4. Thiel G, Rössler OG. Resveratrol regulates gene transcription via activation of stimulus-responsive transcription factors. Pharmacol Res. 2017 Mar;117:166–76.
5. Frémont L. Biological effects of resveratrol. Life Sci. 2000 Jan;66(8):663–73.
6. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006 Jun 26;5(6):493–506.
7. Kulkarni SS, Cantó C. The molecular targets of resveratrol. BiochimBiophys Acta Mol Basis Dis. 2015 Jun;1852(6):1114–23.
8. Gülçin İ. Antioxidant properties of resveratrol: A structure–activity insight. Innov Food Sci Emerg Technol. 2010 Jan;11(1):210–8.
9. Walle T. Bioavailability of resveratrol. Ann N Y Acad Sci. 2011 Jan 24;1215(1):9–15.
10. Chimento A, De Amicis F, Sirianni R, Sinicropi MS, Puoci F, Casaburi I, Saturnino C, Pezzi V. Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol. Int J Mol Sci. 2019 Mar 19;20(6):1381.
11. Amri A, Chaumeil JC, Sfar S, Charrueau C. Administration of resveratrol: What formulation solutions to bioavailability limitations? J Control Release. 2012 Mar;158(2):182–93.
12. Machado ND, Fernández MA, Díaz DD. Recent Strategies in Resveratrol Delivery Systems. Chempluschem. 2019 Jul 10;84(7):951–73.
13. Najafiyan B, Bokaii Hosseini Z, Esmaelian S, Firuzpour F, RahimipourAnaraki S, Kalantari L, Hheidari A, Mesgari H, Nabi-Afjadi M. Unveiling the potential effects of resveratrol in lung cancer treatment: Mechanisms and nanoparticle-based drug delivery strategies. Biomed Pharmacother. 2024 Mar;172:116207.
14. Isailović BD, Kostić IT, Zvonar A, Đorđević VB, Gašperlin M, Nedović VA, Bugarski BM. Resveratrol loaded liposomes produced by different techniques. Innov Food Sci Emerg Technol. 2013 Jul;19:181–9.
15. Chen H, Tuck T, Ji X, Zhou X, Kelly G, Cuerrier A, Zhang J. Quality Assessment of Japanese Knotweed (Fallopia japonica) Grown on Prince Edward Island as a Source of Resveratrol. J Agric Food Chem. 2013 Jul 3;61(26):6383–92.
16. Sales JM, Resurreccion AVA. Resveratrol in Peanuts. Crit Rev Food Sci Nutr. 2014 Jan 17;54(6):734–70.
17. Hasan M, Bae H. An Overview of Stress-Induced Resveratrol Synthesis in Grapes: Perspectives for Resveratrol-Enriched Grape Products. Molecules. 2017 Feb 14;22(2).
18. Hangun-Balkir Y, McKenney ML. Determination of antioxidant activities of berries and resveratrol. Green Chem Lett Rev. 2012 Jun;5(2):147–53.
19. Aldred D, Cairns-Fuller V, Magan N. Environmental factors affect efficacy of some essential oils and resveratrol to control growth and ochratoxin A production by Penicillium verrucosum and Aspergillus westerdijkiae on wheat grain. J Stored Prod Res. 2008;44(4):341–6.
20. Geana EI, Dinca OR, Ionete RE, Artem V, Niculescu VC. Monitoring trans-Resveratrol in Grape Berry Skins During Ripening and in Corresponding Wines by HPLC. Food Technol Biotechnol. 2015 Mar 30;53(1):73–80.
21. Lachman J, Šulc M, Hejtmánková A, Pivec V, Orsák M, others. Content of polyphenolic antioxidants and trans-resveratrol in grapes of different varieties of grapevine (Vitis vinifera L.). J Hortic Sci. 2004;31:63–9.
22. Taquichiri M, Ayarde R, Gutierrez P, Bustos AS, Paredes C, Callisaya JC, Surco JC, Palenque ER, Ghezzi F, Alvarado JA, Peñarrieta JM. High Levels of Resveratrol in Grapes Cultivated at High Altitude Valleys in Bolivia. Int J Fruit Sci. 2014 Jul 3;14(3):311–26.
23. Hurst WJ, Glinski JA, Miller KB, Apgar J, Davey MH, Stuart DA. Survey of the trans -Resveratrol and trans -Piceid Content of Cocoa-Containing and Chocolate Products. J Agric Food Chem. 2008 Sep 24;56(18):8374–8.
24. Paradiso A, D’Amico L, Nicoletti I, Santino A, De Gara L, Giovinazzo G, others. Resveratrol biosynthesis up-regulates the ascorbate/glutathione pathway in transgenic tomato fruit. J Plant Biochem Physiol. 2013;1(2).
25. Niu J, Hou Z, Ou Z, Hui W. Comparative study of effects of resveratrol, 1-MCP and DPA treatments on postharvest quality and superficial scald of ‘Starkrimson’ apples. Sci Hortic. 2018 Oct;240:516–21.
26. Francini A, Sebastiani L. Phenolic Compounds in Apple (Malus x domestica Borkh.): Compounds Characterization and Stability during Postharvest and after Processing. Antioxidants. 2013 Sep 18;2(3):181–93.
27. Xu Y, Fang M, Li X, Wang D, Yu L, Ma F, Jiang J, Zhang L, Li P. Contributions of Common Foods to Resveratrol Intake in the Chinese Diet. Foods. 2024 Apr 21;13(8):1267.
28. Serra AT, Matias AA, Frade RFM, Duarte RO, Feliciano RP, Bronze MR, Figueira ME, de Carvalho A, Duarte CMM. Characterization of traditional and exotic apple varieties from Portugal. Part 2 – Antioxidant and antiproliferative activities. J Funct Foods. 2010 Jan;2(1):46–53.
29. Shrikanta A, Kumar A, Govindaswamy V. Resveratrol content and antioxidant properties of underutilized fruits. J Food Sci Technol. 2015 Jan;52(1):383–90.
30. Kurita S, Kashiwagi T, Ebisu T, Shimamura T, Ukeda H. Content of resveratrol and glycoside and its contribution to the antioxidative capacity of Polygonum cuspidatum (Itadori) harvested in Kochi. BiosciBiotechnolBiochem. 2014 Mar 4;78(3):499–502.
31. Brown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, Vasilinin G, Sen A, Schinas AM, Piccirilli G, Brown K, Steward WP, Gescher AJ, Brenner DE. Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis. Cancer Res. 2010 Nov 15;70(22):9003–11.
32. Chow HHS, Garland LL, Hsu CH, Vining DR, Chew WM, Miller JA, Perloff M, Crowell JA, Alberts DS. Resveratrol Modulates Drug- and Carcinogen-Metabolizing Enzymes in a Healthy Volunteer Study. Cancer Prev Res. 2010 Sep 1;3(9):1168–75.
33. Tomé-Carneiro J, Gonzálvez M, Larrosa M, Yáñez-Gascón MJ, García-Almagro FJ, Ruiz-Ros JA, García-Conesa MT, Tomás-Barberán FA, Espín JC. One-Year Consumption of a Grape Nutraceutical Containing Resveratrol Improves the Inflammatory and Fibrinolytic Status of Patients in Primary Prevention of Cardiovascular Disease. Am J Cardiol. 2012 Aug;110(3):356–63.
34. Smoliga JM, Baur JA, Hausenblas HA. Resveratrol and health – A comprehensive review of human clinical trials. Mol Nutr Food Res. 2011 Aug 20;55(8):1129–41.
35. Pangeni R, Sahni JK, Ali J, Sharma S, Baboota S. Resveratrol: review on therapeutic potential and recent advances in drug delivery. Expert Opin Drug Deliv. 2014 Aug 15;11(8):1285–98.
36. Price NL, Gomes AP, Ling AJY, Duarte FV, Martin-Montalvo A, North BJ, Agarwal B, Ye L, Ramadori G, Teodoro JS, Hubbard BP, Varela AT, Davis JG, Varamini B, Hafner A, Moaddel R, Rolo AP, Coppari R, Palmeira CM, de Cabo R, Baur JA, Sinclair DA. SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial Function. Cell Metab. 2012 May;15(5):675–90.
37. Pouremamali F, Pouremamali A, Dadashpour M, Soozangar N, Jeddi F. An update of Nrf2 activators and inhibitors in cancer prevention/promotion. Cell Commun Signal. 2022 Dec 30;20(1):100.
38. Movahed A, Nabipour I, Lieben Louis X, Thandapilly SJ, Yu L, Kalantarhormozi M, Rekabpour SJ, Netticadan T. Antihyperglycemic Effects of Short Term Resveratrol Supplementation in Type 2 Diabetic Patients. Evid Based Complement Alternat Med. 2013;2013:1–11.
39. Zhou DD, Luo M, Huang SY, Saimaiti A, Shang A, Gan RY, Li HB. Effects and Mechanisms of Resveratrol on Aging and Age‐Related Diseases. Oxid Med Cell Longev. 2021 Jan 12;2021(1).
40. Csiszar A. Anti‐inflammatory effects of resveratrol: possible role in prevention of age‐related cardiovascular disease. Ann N Y Acad Sci. 2011 Jan 24;1215(1):117–22.
41. Meng T, Xiao D, Muhammed A, Deng J, Chen L, He J. Anti-Inflammatory Action and Mechanisms of Resveratrol. Molecules. 2021 Jan 5;26(1):229.
42. Ma C, Wang Y, Dong L, Li M, Cai W. Anti-inflammatory effect of resveratrol through the suppression of NF-κB and JAK/STAT signaling pathways. Acta BiochimBiophys Sin. 2015 Mar 1;47(3):207–13.
43. Dolinsky VW, Chakrabarti S, Pereira TJ, Oka T, Levasseur J, Beker D, Zordoky BN, Morton JS, Nagendran J, Lopaschuk GD, Davidge ST, Dyck JRB. Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice. BBA Mol basis dis. 2013 Oct;1832(10):1723–33.
44. Simental-Mendía LE, Guerrero-Romero F. Effect of resveratrol supplementation on lipid profile in subjects with dyslipidemia: A randomized double-blind, placebo-controlled trial. Nutrition. 2019 Feb;58:7–10.
45. Xia N, Förstermann U, Li H. Resveratrol and Endothelial Nitric Oxide. Molecules. 2014 Oct 9;19(10):16102–21.
46. Ojha R, Pranesh K, Bhavin V. A.Randomized active controlled clinical study to evaluate efficacy and safety of resveratrol as an adjuvant therapy in patients with hypertension. Asian J Pharm Clin Res. 2016 Jan 1;10(1):376.
47. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 2004;24(5A):2783–840.
48. Athar M, Back JH, Kopelovich L, Bickers DR, Kim AL. Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms. Arch Biochem Biophys. 2009 Jun;486(2):95–102.
49. Xie Y, Wang Y, Xiang W, Wang Q, Cao Y. Molecular Mechanisms of the Action of Myricetin in Cancer. Mini Rev Med Chem. 2020;20(2):123–33.
50. Thongsom S, Racha S, Petsri K, Ei ZZ, Visuttijai K, Moriue S, Yokoya M, Chanvorachote P. Structural modification of resveratrol analogue exhibits anticancer activity against lung cancer stem cells via suppression of Akt signaling pathway. BMC Complement Med Ther. 2023 Jun 3;23(1):183.
51. Innets B, Thongsom S, Petsri K, Racha S, Yokoya M, Moriue S, Chaotham C, Chanvorachote P. Akt/mTOR Targeting Activity of Resveratrol Derivatives in Non-Small Lung Cancer. Molecules. 2022 Nov 27;27(23):8268.
52. Brasnyó P, Molnár GA, Mohás M, Markó L, Laczy B, Cseh J, Mikolás E, Szijártó IA, Mérei A, Halmai R, Mészáros LG, Sümegi B, Wittmann I. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr. 2011 Aug;106(3):383–9.
53. Zhu P, Jin Y, Sun J, Zhou X. The efficacy of resveratrol supplementation on inflammation and oxidative stress in type-2 diabetes mellitus patients: randomized double-blind placebo meta-analysis. Front Endocrinol (Lausanne). 2025 Jan 13;15.
54. Szkudelski T, Szkudelska K. Resveratrol and diabetes: from animal to human studies. BBA Mol. Basis Dis. 2015 Jun;1852(6):1145–54.
55. Chachay VS, Macdonald GA, Martin JH, Whitehead JP, O’Moore–Sullivan TM, Lee P, Franklin M, Klein K, Taylor PJ, Ferguson M, Coombes JS, Thomas GP, Cowin GJ, Kirkpatrick CMJ, Prins JB, Hickman IJ. Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2014 Dec;12(12):2092-2103.e6.
56. Tejada S, Capó X, Mascaró CM, Monserrat-Mesquida M, Quetglas-Llabrés MM, Pons A, Tur JA, Sureda A. Hepatoprotective Effects of Resveratrol in Non-Alcoholic Fatty Live Disease. Curr Pharm Des. 2021 Sep 1;27(22):2558–70.
57. Jia R, Li Y, Cao L, Du J, Zheng T, Qian H, Gu Z, Jeney G, Xu P, Yin G. Antioxidative, anti-inflammatory and hepatoprotective effects of resveratrol on oxidative stress-induced liver damage in tilapia (Oreochromis niloticus). Comp BiochemPhysiol C ToxicolPharmacol. 2019 Jan;215:56–66.
58. Gezer A, Ustundag H, Mendil AS, Bedir G, Duysak L. Hepatoprotective effects of resveratrol on α-amanitin-induced liver toxicity in rats. Toxicon. 2024 Aug;247:107855.
59. Albani D, Polito L, Signorini A, Forloni G. Neuroprotective properties of resveratrol in different neurodegenerative disorders. BioFactors. 2010 Sep 16;36(5):370–6.
60. Bastianetto S, Ménard C, Quirion R. Neuroprotective action of resveratrol. BBA - Mol. basis dis. 2015 Jun;1852(6):1195–201.
61. Tresguerres IF, Tamimi F, Eimar H, Barralet J, Torres J, Blanco L, Tresguerres JAF. Resveratrol As Anti-Aging Therapy for Age-Related Bone Loss. Rejuvenation Res. 2014 Oct;17(5):439–45.
62. Alarcón de la Lastra C, Villegas I. Resveratrol as an anti-inflammatory and anti-aging agent: Mechanisms and clinical implications. Mol Nutr Food Res. 2005 May;49(5):405–30.
63. Wang W, Zhang LM, Guo C, Han JF. Resveratrol promotes osteoblastic differentiation in a rat model of postmenopausal osteoporosis by regulating autophagy. NutrMetab (Lond). 2020 Dec 16;17(1):29.
64. Li Q, Yang G, Xu H, Tang S, Lee WY wai. Effects of resveratrol supplementation on bone quality: a systematic review and meta-analysis of randomized controlled trials. BMC Complement Med Ther. 2021 Dec 22;21(1):214.
65. Vestergaard M, Ingmer H. Antibacterial and antifungal properties of resveratrol. Int J Antimicrob Agents. 2019 Jun;53(6):716–23.
66. Karamese M, Dicle Y. The Antibacterial and Antibiofilm Activities of Resveratrol on Gram-positive and Gram-negative Bacteria. Kafkas J Med Sci. 2022;12(3):201–6.
67. Ratz-Łyko A, Arct J. Resveratrol as an active ingredient for cosmetic and dermatological applications: a review. J Cosmet Laser Ther. 2019 Feb 17;21(2):84–90.
68. Mascarenhas-Melo F, Araújo A, Rodrigues M, Mathur A, Gonçalves M, Tanwar K, Heidarizadeh F, Nejaddehbashi F, Rahdar A, Mazzola P, Veiga F, Paiva-Santos A. Dermatological Bioactivities of Resveratrol and Nanotechnology Strategies to Boost Its Efficacy—An Updated Review. Cosmetics. 2023 Apr 24;10(3):68.
69. Kitada M, Koya D. Renal Protective Effects of Resveratrol. Oxid Med Cell Longev. 2013;2013:1–7.
70. Dos Santos AB, Santos‐Terra J, Carletti JV, Deckmann I, Gottfried C. Molecular Alterations in Ferroptosis and the Effects of Resveratrol: A Systematic Review. J Biochem Mol Toxicol. 2025 Jul 30;39(7).
71. Murcia MA, Martínez-Tomé M. Antioxidant Activity of Resveratrol Compared with Common Food Additives. J Food Prot. 2001 Mar;64(3):379–84.
72. Martins LAM, Coelho BP, Behr G, Pettenuzzo LF, Souza ICC, Moreira JCF, Borojevic R, Gottfried C, Guma FCR. Resveratrol Induces Pro-oxidant Effects and Time-Dependent Resistance to Cytotoxicity in Activated Hepatic Stellate Cells. Cell BiochemBiophys. 2014 Mar 21;68(2):247–57.
73. Zhang J, Fu Q, Wang Y, Mu Y, Ren H, Xue L, Liu J. Resveratrol alleviates oxidative stress, inflammatory cytokine expression and apoptosis induced by nanoplastics in the hemocytes of abalone (Haliotis discus hannai). Aquac Rep. 2025 Sep;43:102983.
74. Yang M, Shen Y, Zhao S, Zhang R, Dong W, Lei X. Protective effect of resveratrol on mitochondrial biogenesis during hyperoxia-induced brain injury in neonatal pups. Neurosci. 2023 Apr 25;24(1):27.
75. Wu S kun, Wang L, Wang F, Zhang J. Resveratrol improved mitochondrial biogenesis by activating SIRT1/PGC-1α signal pathway in SAP. Sci Rep. 2024 Oct 31;14(1):26216.
76. Shaito A, Al-Mansoob M, Ahmad SMS, Haider MZ, Eid AH, Posadino AM, Pintus G, Giordo R. Resveratrol-Mediated Regulation of Mitochondria Biogenesis-associated Pathways in Neurodegenerative Diseases: Molecular Insights and Potential Therapeutic Applications. Curr Neuropharmacol. 2023 May;21(5):1184–201.
77. Brown K, Theofanous D, Britton RG, Aburido G, Pepper C, Sri Undru S, Howells L. Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Resveratrol Clinical Trials to Highlight Gaps and Opportunities. Int J Mol Sci. 2024 Jan 6;25(2):747.
78. Li J, Koonyosying P, Korsieporn W, Paradee N, Hutachok N, Xu H, Ma Y, Chuljerm H, Srichairatanakool S. Deferiprone–resveratrol hybrid attenuates iron accumulation, oxidative stress, and antioxidant defenses in iron-loaded human Huh7 hepatic cells. Front Mol Biosci. 2024 Mar 20;11.
79. Kontoghiorghes GJ. New Approaches and Strategies for the Repurposing of Iron Chelating/Antioxidant Drugs for Diseases of Free Radical Pathology in Medicine. Antioxidants. 2025 Aug 10;14(8):982.
80. Pal K, Raghuram G V., Dsouza J, Shinde S, Jadhav V, Shaikh A, Rane B, Tandel H, Kondhalkar D, Chaudhary S, Mittra I. A pro-oxidant combination of resveratrol and copper down-regulates multiple biological hallmarks of ageing and neurodegeneration in mice. Sci Rep. 2022 Oct 14;12(1):17209.
81. Ahmad A, Syed FA, Singh S, Hadi SM. Prooxidant activity of resveratrol in the presence of copper ions: Mutagenicity in plasmid DNA. Toxicol Lett. 2005 Oct;159(1):1–12.
82. Farhan M, Rizvi A. Understanding the Prooxidant Action of Plant Polyphenols in the Cellular Microenvironment of Malignant Cells: Role of Copper and Therapeutic Implications. Front Pharmacol. 2022 Jun 20;13.
83. Gu XS, Wang ZB, Ye Z, Lei JP, Li L, Su DF, Zheng X. Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure. Genet Mol Res. 2014;13(1):323–35.
84. Bonnefont-Rousselot D. Resveratrol and Cardiovascular Diseases. Nutrients. 2016 May 2;8(5):250.
85. Bagul PK, Deepthi N, Sultana R, Banerjee SK. Resveratrol ameliorates cardiac oxidative stress in diabetes through deacetylation of NFkB-p65 and histone 3. J NutrBiochem. 2015 Nov;26(11):1298–307.
86. Dyck GJB, Raj P, Zieroth S, Dyck JRB, Ezekowitz JA. The Effects of Resveratrol in Patients with Cardiovascular Disease and Heart Failure: A Narrative Review. Int J Mol Sci. 2019 Feb 19;20(4):904.
87. Ko JH, Sethi G, Um JY, Shanmugam MK, Arfuso F, Kumar AP, Bishayee A, Ahn KS. The Role of Resveratrol in Cancer Therapy. Int J Mol Sci. 2017 Dec 1;18(12):2589.
88. Yang Q, Meng D, Zhang Q, Wang J. Advances in the role of resveratrol and its mechanism of action in common gynecological tumors. Front Pharmacol. 2024 Jul 17;15.
89. Song B, Wang W, Tang X, Goh RMWJ, Thuya WL, Ho PCL, Chen L, Wang L. Inhibitory Potential of Resveratrol in Cancer Metastasis: From Biology to Therapy. Cancers (Basel). 2023 May 14;15(10):2758.
90. Ferraresi A, Thongchot S, Isidoro C. Resveratrol Promotes Self-digestion to Put Cancer to Sleep. J Cancer Prev. 2024 Mar 30;29(1):1–5.
91. Brown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, Vasilinin G, Sen A, Schinas AM, Piccirilli G, Brown K, Steward WP, Gescher AJ, Brenner DE. Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis. Cancer Res. 2010 Nov 15;70(22):9003–11.
92. Patel KR, Brown VA, Jones DJL, Britton RG, Hemingway D, Miller AS, West KP, Booth TD, Perloff M, Crowell JA, Brenner DE, Steward WP, Gescher AJ, Brown K. Clinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer Patients. Cancer Res. 2010 Oct 1;70(19):7392–9.
93. Xiao X, Wu X, Li W, You F, Guo J. Therapeutic effects and safety of resveratrol for lung cancer: an updated preclinical systematic review and meta-analysis. Front Nutr. 2025 Aug 29;12.
94. Varoni EM, Lo Faro AF, Sharifi-Rad J, Iriti M. Anticancer Molecular Mechanisms of Resveratrol. Front Nutr. 2016 Apr 12;3.
95. Kohandel Z, Darrudi M, Naseri K, Samini F, Aschner M, Pourbagher-Shahri AM, Samarghandian S. The Role of Resveratrol in Aging and Senescence: A Focus on Molecular Mechanisms. Curr Mol Med. 2024 Jul;24(7):867–75.
96. Kim EN, Lim JH, Kim MY, Ban TH, Jang IA, Yoon HE, Park CW, Chang YS, Choi BS. Resveratrol, an Nrf2 activator, ameliorates aging-related progressive renal injury. Aging. 2018 Jan 11;10(1):83–99.
97. Novelle MG, Wahl D, Diéguez C, Bernier M, de Cabo R. Resveratrol supplementation: Where are we now and where should we go? Ageing Res Rev. 2015 May;21:1–15.
98. Timmers S, Konings E, Bilet L, Houtkooper RH, van de Weijer T, Goossens GH, Hoeks J, van der Krieken S, Ryu D, Kersten S, Moonen-Kornips E, Hesselink MKC, Kunz I, Schrauwen-Hinderling VB, Blaak EE, Auwerx J, Schrauwen P. Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans. Cell Metab. 2011 Nov;14(5):612–22.
99. de Ligt M, Bruls YMH, Hansen J, Habets MF, Havekes B, Nascimento EBM, Moonen-Kornips E, Schaart G, Schrauwen-Hinderling VB, van Marken Lichtenbelt W, Schrauwen P. Resveratrol improves ex vivo mitochondrial function but does not affect insulin sensitivity or brown adipose tissue in first degree relatives of patients with type 2 diabetes. Mol Metab. 2018 Jun;12:39–47.
100. Franco FN, Arrieta OAP, de Mello Silva B, Aragão MM, Nagem RAP, de Araújo GR, Chaves MM. Nrf2 cell signaling pathway is responsible for the antioxidant effect of resveratrol in aging. GeriatrGerontol Int. 2024 Sep 8;24(9):954–61.
101. Alesci A, Nicosia N, Fumia A, Giorgianni F, Santini A, Cicero N. Resveratrol and Immune Cells: A Link to Improve Human Health. Molecules. 2022 Jan 10;27(2):424.
102. Turner RS, Thomas RG, Craft S, van Dyck CH, Mintzer J, Reynolds BA, Brewer JB, Rissman RA, Raman R, Aisen PS, Mintzer J, Reynolds BA, Karlawish J, Galasko D, Heidebrink J, Aggarwal N, Graff-Radford N, Sano M, Petersen R, Bell K, Doody R, Smith A, Bernick C, Porteinsson A, Tariot P, Mulnard R, Lerner A, Schneider L, Burns J, Raskind M, Ferris S, Jicha G, Quiceno M, Obisesan T, Rosenberg P, Weintraub D, Kieburtz K, Miller B, Kryscio R, Alexopoulis G. A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology. 2015 Oct 20;85(16):1383–91.
103. Lopez MS, Dempsey RJ, Vemuganti R. Resveratrol neuroprotection in stroke and traumatic CNS injury. Neurochem Int. 2015 Oct;89:75–82.
104. Shin JA, Lee H, Lim YK, Koh Y, Choi JH, Park EM. Therapeutic effects of resveratrol during acute periods following experimental ischemic stroke. J Neuroimmunol. 2010 Oct;227(1–2):93–100.
105. Komorowska J, Wątroba M, Bednarzak M, Grabowska AD, Szukiewicz D. Anti-Inflammatory Action of Resveratrol in the Central Nervous System in Relation to Glucose Concentration—An In Vitro Study on a Blood–Brain Barrier Model. Int J Mol Sci. 2024 Mar 7;25(6):3110.
106. Mathew LS, Marathe A, Aman A, Vats A, Joy T, Rao YL. Bridging the molecular and clinical aspects of resveratrol in Alzheimer’s disease: a review. 3 Biotech. 2025 Sep 6;15(9):284.
107. Su CF, Jiang L, Zhang XW, Iyaswamy A, Li M. Resveratrol in Rodent Models of Parkinson’s Disease: A Systematic Review of Experimental Studies. Front Pharmacol. 2021 Apr 22;12.
108. Zhang F, Shi JS, Zhou H, Wilson B, Hong JS, Gao HM. Resveratrol Protects Dopamine Neurons Against Lipopolysaccharide-Induced Neurotoxicity through Its Anti-Inflammatory Actions. Mol Pharmacol. 2010 Sep;78(3):466–77.
109. Cebrián R, Li Q, Peñalver P, Belmonte-Reche E, Andrés-Bilbao M, Lucas R, de Paz MV, Kuipers OP, Morales JC. Chemically Tuning Resveratrol for the Effective Killing of Gram-Positive Pathogens. J Nat Prod. 2022 Jun 24;85(6):1459–73.
110. Houillé B, Papon N, Boudesocque L, Bourdeaud E, Besseau S, Courdavault V, Enguehard-Gueiffier C, Delanoue G, Guérin L, Bouchara JP, Clastre M, Giglioli-Guivarc’h N, Guillard J, Lanoue A. Antifungal Activity of Resveratrol Derivatives against Candida Species. J Nat Prod. 2014 Jul 25;77(7):1658–62.
111. Docherty JJ, Fu MMH, Stiffler BS, Limperos RJ, Pokabla CM, DeLucia AL. Resveratrol inhibition of herpes simplex virus replication. Antiviral Res. 1999 Oct;43(3):145–55.
112. Annunziata G, Maisto M, Schisano C, Ciampaglia R, Narciso V, Tenore GC, Novellino E. Resveratrol as a Novel Anti-Herpes Simplex Virus Nutraceutical Agent: An Overview. Viruses. 2018 Sep 3;10(9):473.
113. Palamara AT, Nencioni L, Aquilano K, De Chiara G, Hernandez L, Cozzolino F, Ciriolo MR, Garaci E. Inhibition of Influenza A Virus Replication by Resveratrol. J Infect Dis. 2005 May 15;191(10):1719–29.
114. Lee S, Yoon KD, Lee M, Cho Y, Choi G, Jang H, Kim B, Jung D, Oh J, Kim G, Oh J, Jeong Y, Kwon HJ, Bae SK, Min D, Windisch MP, Heo T, Lee C. Identification of a resveratrol tetramer as a potent inhibitor of hepatitis C virus helicase. Br J Pharmacol. 2016 Jan 25;173(1):191–211.
115. van Brummelen R, van Brummelen AC. The potential role of resveratrol as supportive antiviral in treating conditions such as COVID-19 – A formulator’s perspective. Biomed Pharmacother. 2022 Apr;148:112767.
116. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 2006 Dec 15;127(6):1109–22.
117. Liu X, Gu X, Zhang J, Li X, Wei X, Jiang S, Li W. Resveratrol delays the progression of diabetic nephropathy through multiple pathways: A dose–response meta‐analysis based on animal models. J Diabetes. 2024 Sep 12;16(9).
118. Camins A, Junyent F, Verdaguer E, Beas-Zarate C, Rojas-Mayorquín AE, Ortuño-Sahagún D, Pallàs M. Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases. Pharmaceuticals. 2009 Dec 15;2(3):194–205.
119. Hector KL, Lagisz M, Nakagawa S. The effect of resveratrol on longevity across species: a meta-analysis. Biol Lett. 2012 Oct 23;8(5):790–3.
120. Pallauf K, Rimbach G, Maria Rupp P, Chin D, M.A. Wolf I. Resveratrol and Lifespan in Model Organisms. Curr Med Chem. 2016 Dec 23;23(41):4639–80.
121. Song J, Liu L, Hao K, Mao S, Tang Y, Tong X, Dai F. Resveratrol elongates the lifespan and improves antioxidant activity in the silkworm Bombyx mori. J Pharm Anal. 2021 Jun;11(3):374–82.
122. Potter GA, Patterson LH, Wanogho E, Perry PJ, Butler PC, Ijaz T, Ruparelia KC, Lamb JH, Farmer PB, Stanley LA, Burke MD. The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. Br J Cancer. 2002 Mar 26;86(5):774–8.
123. Gambini J, Inglés M, Olaso G, Lopez-Grueso R, Bonet-Costa V, Gimeno-Mallench L, Mas-Bargues C, Abdelaziz KM, Gomez-Cabrera MC, Vina J, Borras C. Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans. Oxid Med Cell Longev. 2015;2015:1–13.
Published
How to Cite
Issue
Section
Copyright (c) 2025 LALIT P. DEWALKAR
This work is licensed under a Creative Commons Attribution 4.0 International License.
